查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1268872

DNA聚合酵素市场规模,份额,趋势分析报告,类型(Taq聚合酵素,Pfu聚合酵素,专有酵素混合物),应用,用途,地区,细分市场预测2023-2030

DNA Polymerase Market Size, Share & Trends Analysis Report By Type (Taq Polymerase, Pfu Polymerase, Proprietary Enzyme Blends), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

DNA 聚合酵素市场增长和趋势：

根据 Grand View Research, Inc. 的最新报告，全球 DNA 聚合酵素市场预计到 2030 年将达到 1.365 亿美元。

预计从 2023 年到 2030 年，复合年增长率将达到 1.30%。 DNA 聚合酵素是参与生物体 DNA 复製和修復的必需酵素。 近年来，由于分子诊断、基因工程和药物开发等各种应用对 DNA 聚合酵素的需求不断增加，这些聚合酵素的市场经历了显着增长。 此外，这些聚合酵素在製药、农业和法医学等各个行业的使用越来越多，进一步推动了这一市场的扩张。

此外，遗传病和癌症患病率上升也是推动市场增长的因素。 遗传和罕见病 (GARD) 信息中心报告说，有 7,000 多种罕见病。 仅在美国，估计就有 25 至 3000 万人患有罕见疾病，而且这个数字还在继续增长。 此外，已知至少有20万人是遗传病的倖存者，英国每年有超过3万名婴儿和儿童被诊断出患有遗传病，导致超过240万人患有各种遗传病。 预计这一趋势将在预测期内持续，从而导致对 DNA 聚合酵素和相关产品的需求增加。

COVID-19 大流行增加了对诊断和治疗药物开发的需求，并且市场正在迅速扩大。 为了提高我们对病毒的理解并製定有效的检测策略，研究人员和医疗保健从业者在各种分子诊断技术（如 PCR 和 RT-PCR）中使用 DNA 聚合酵素。 这种不断增长的需求导致了市场的显着扩张。 抗击 COVID-19 的紧迫性正在推动科学创新和协作研究工作，以开发新的诊断工具和治疗方法。 例如，生物技术公司 Ginkgo Bioworks 推出了 Concentric by Ginkgo，这是一项依赖 PCR 等基于 DNA 聚合酵素的技术的大规模 COVID-19 检测服务。 这项工作证明了 DNA 聚合酵素在创新诊断解决方案中的作用。

新型 DNA 聚合酵素的开发具有增强的特性，例如高保真度、可加工性和对抑製剂的耐受性，扩大了它们的应用范围。 这些进步使研究人员能够进行更复杂的实验并探索以前无法进入的基因组区域。 随着对高效和准确的 DNA 聚合酵素的需求增加，这一领域的创新有望进一步推动市场。

此外，增加对个性化医学研究的投资以及对其好处的认识不断提高预计将在未来几年推动市场发展。 例如，2020年12月，精准医疗科技公司腾邦科技获得2亿美元G-2轮融资，有效估值达到81亿美元。 该公司计划利用额外资金扩大业务并专注于一系列疾病，包括传染病、忧郁症和心臟病。 个性化医疗是一个新领域，旨在根据个人的基因构成提供个性化治疗。 DNA 聚合酵素在个性化医疗必不可少的测序中发挥着重要作用。

DNA 聚合酵素市场报告亮点

  • 按类型划分，Taq 聚合酵素细分市场在 2022 年以 53.99% 的份额占据市场主导地位。 Taq 聚合酵素是 PCR 技术中常用的一种 DNA 聚合酵素。 随着遗传学和分子生物学研究的不断扩大，对 PCR 的需求预计会增加，从而推动这一领域的增长。
  • 由于 DNA 扩增技术广泛用于诊断和研究目的，聚合酵素炼式反应部分在 2022 年的应用部分中占有最大份额，达到 74.85%。
  • 由于遗传病和传染病（如 COVID-19）的流行率上升，导致基于聚合酵素的检测方案的采用激增，到 2022 年，医院和诊断中心部分将占据 41.65% 的最大市场份额。占据。
  • 北美在 2022 年占据了 47.25% 的市场份额，在市场上确立了稳固的地位。 该地区是许多着名的生物技术和製药公司的所在地，这些公司大力投资于新药和治疗的研发。

内容

第 1 章调查方法及范围

  • 资讯采购
  • 资讯或数据分析
  • 市场范围和细分定义
  • 市场模型
    • 按公司市场份额进行的市场调查
    • 区域分析

第 2 章执行摘要

  • 市场概况
  • 片段快照
  • 竞争格局快照

第 3 章市场变量、趋势和范围

  • 市场细分和范围
  • 市场体系展望
    • 母公司市场展望
    • 相关/补充市场展望
  • 市场趋势和前景
  • 市场动态
    • 市场促进因素
      • 越来越多地采用用于诊断和调查目的的测序技术
      • 在医疗保健领域更多地采用个性化医疗
      • 慢性病和传染病的患病率增加
    • 市场抑制因素分析
      • 增加聚合酵素链反应技术的替代技术
      • 要求熟练的专业人员使用 PCR 和 NGS 技术
  • 商业环境分析
    • SWOT 分析；按因素（政治/法律、经济/技术）
    • 波特的五力分析
  • COVID-19 影响分析

第 4 章类型业务分析

  • DNA 聚合酵素市场：类型变异分析
  • Taq聚合酵素
  • Pfu聚合酵素
  • 原味酵素混合物
  • 其他

第 5 章应用业务分析

  • DNA 聚合酵素市场：应用变化分析
  • 聚合酵素链反应
  • DNA测序
  • DNA克隆
  • 其他

第 6 章最终用途业务分析

  • DNA 聚合酵素市场：最终用途的变化分析
  • 製药和生物技术公司
  • 学术研究机构
  • 医院和诊断中心
  • 其他

第 7 章区域业务分析

  • 2022 年和 2030 年各地区 DNA 聚合酵素市场份额
  • 北美
    • SWOT 分析
    • 美国
    • 加拿大
  • 欧洲
    • SWOT 分析
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • SWOT 分析
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳大利亚
    • 泰国
  • 拉丁美洲
    • SWOT 分析
    • 巴西
    • 墨西哥
    • 阿根廷
  • 多边环境协定
    • SWOT 分析
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 科威特

第 8 章竞争格局

  • 公司分类
  • 战略规划
  • 2022 年公司市场份额分析
  • 公司简介/名单
    • Thermo Fisher Scientific, Inc.
      • 概览
      • 财务业绩（净收入/销售额/EBITDA/毛利率）
      • 产品基准
      • 战略举措
    • Agilent Technologies
      • 概览
      • 财务业绩（净收入/销售额/EBITDA/毛利率）
      • 产品基准
      • 战略举措
    • Merck KGaA
      • 概览
      • 财务业绩（净收入/销售额/EBITDA/毛利率）
      • 产品基准
      • 战略举措
    • Danaher
      • 概览
      • 财务业绩（净收入/销售额/EBITDA/毛利率）
      • 产品基准
      • 战略举措
    • QIAGEN
      • 概览
      • 财务业绩（净收入/销售额/EBITDA/毛利率）
      • 产品基准
      • 战略举措
    • Hoffmann-La Roche Ltd
      • 概览
      • 财务业绩（净收入/销售额/EBITDA/毛利率）
      • 产品基准
      • 战略举措
    • Bio-Rad Laboratories, Inc.;
      • 概览
      • 财务业绩（净收入/销售额/EBITDA/毛利率）
      • 产品基准
      • 战略举措
    • Takara Bio, Inc.
      • 概览
      • 财务业绩（净收入/销售额/EBITDA/毛利率）
      • 产品基准
      • 战略举措
    • Promega Corporation
      • 概览
      • 财务业绩（净收入/销售额/EBITDA/毛利率）
      • 产品基准
      • 战略举措
    • New England Biolabs
      • 概览
      • 财务业绩（净收入/销售额/EBITDA/毛利率）
      • 产品基准
      • 战略举措
Product Code: GVR-4-68040-059-4

DNA Polymerase Market Growth & Trends:

The global DNA polymerase market size is expected to reach USD 136.5 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 1.30% from 2023 to 2030. DNA polymerase are essential enzymes involved in the replication and repair of DNA in living organisms. These polymerases market has experienced significant growth in recent years due to the increasing demand for DNA polymerases in various applications, such as molecular diagnostics, genetic engineering, and drug development. Moreover, the increasing use of such polymerases in various industries, such as pharmaceuticals, agriculture, and forensics, has further fueled the expansion of this market.

In addition, rising prevalence of genetic disorders and cancers is another factor is driving the growth of the market. According to the Genetic and Rare Disease (GARD) Information Centre reports there are more than 7,000 rare diseases. In the U.S. alone, it is estimated that between 25 million and 30 million people are living with a rare disease, and this number continues to rise. Additionally, at least 200,000 people are known survivors of genetic disorders, while over 30,000 babies and children are diagnosed annually with genetic disorders in the UK, resulting in more than 2.4 million survivors of various genetic conditions. This trend is expected to continue over the forecast period, leading to a growing demand for DNA polymerase and related products.

The COVID-19 pandemic has led to an increased demand for diagnostics and therapeutic development, resulting in a surge in the market. To better understand the virus and develop effective testing strategies, researchers and healthcare professionals have relied on DNA polymerases for various molecular diagnostic techniques, such as PCR and RT-PCR. This increased demand has resulted in a significant expansion of the market. The urgency to combat COVID-19 has propelled scientific innovation and collaboration efforts to develop new diagnostic tools and therapies. For instance, Ginkgo Bioworks, a biotechnology company, has launched Concentric by Ginkgo, a large-scale COVID-19 testing service that depends on DNA polymerase-based techniques like PCR. This initiative showcases the role of DNA polymerases in innovative diagnostic solutions.

The development of novel DNA polymerase with enhanced properties, such as high fidelity, processivity, and resistance to inhibitors, has expanded their range of applications. These advancements have allowed researchers to conduct more complex experiments and explore previously inaccessible areas of the genome. As the demand for efficient and accurate DNA polymerases increases, innovations in this area are expected to boost the market further.

Furthermore, the growing investment in personalized medicine research and the rising awareness of its benefits are expected to drive the market in the coming years. For instance, in December 2020, Tempus, a precision medicine technology company, secured USD 200 million in Series G-2 funding, leading to a substantial valuation of USD 8.1 billion. The company plans to use the additional funding to expand its operations and focus on a range of diseases, including infectious diseases, depression, and cardiology. Personalized medicine is an emerging field that aims to provide tailored treatment options based on an individual's genetic makeup. DNA polymerase play a crucial role in sequencing, which is an essential component of personalized medicine.

DNA Polymerase Market Report Highlights:

  • By type, the Taq polymerase segment dominated the market with a share of 53.99% in 2022. Taq polymerases are a type of DNA polymerases that is commonly used in the PCR technique. As research in genetics and molecular biology continues to expand, the demand for PCR is expected to increase, driving the growth of this segment
  • The polymerase chain reaction segment accounted for the largest share of 74.85% in the application segment in 2022, due to the widespread use of the DNA amplification technique for diagnostic and research purposes
  • The hospitals and diagnostic centers segment accounted for the largest market share of 41.65% in 2022 due to the increasing prevalence of genetic disorders and infectious diseases like COVID-19 which led to a surge in the adoption of polymerase-based testing options
  • North America has established a strong regional position in the market with 47.25% share in 2022, which can be attributed to the high demand for biotechnology techniques. The region is home to numerous prominent biotech and pharmaceutical companies that invest heavily in research and development of new drugs and therapies.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, by Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation And Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends And Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Market Drivers
      • 3.4.1.1. Increasing Adoption Of Sequencing Technologies For Diagnostic And Research Purposes
      • 3.4.1.2. Rising Adoption Of Personalized Medicine In Healthcare
      • 3.4.1.3. Increasing Prevalence Of Chronic And Infectious Diseases
    • 3.4.2. Market Restraint Analysis
      • 3.4.2.1. Increasing Number Of Alternatives To Polymerase Chain Reaction Technologies
      • 3.4.2.2. Requirement Of Skilled Professional For Handling PCR and NGS Technologies
  • 3.5. Business Environment Analysis
    • 3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.5.2. Porter's Five Forces Analysis
  • 3.6. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. DNA Polymerases Market: Type Movement Analysis
  • 4.2. Taq Polymerase
    • 4.2.1. Taq Polymerase Market, 2018 - 2030 (USD Million)
  • 4.3. Pfu Polymerase
    • 4.3.1. Pfu Polymerase Market, 2018 - 2030 (USD Million)
  • 4.4. Proprietary Enzyme Blends
    • 4.4.1. Proprietary Enzyme Blends Polymerase Market, 2018 - 2030 (USD Million)
  • 4.5. Others
    • 4.5.1. Other Types Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. DNA Polymerases Market: Application Movement Analysis
  • 5.2. Polymerase Chain Reaction
    • 5.2.1. Polymerase Chain Reaction Market, 2018 - 2030 (USD Million)
  • 5.3. DNA Sequencing
    • 5.3.1. DNA Sequencing Market, 2018 - 2030 (USD Million)
  • 5.4. DNA Cloning
    • 5.4.1. DNA Cloning Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Other Applications Market, 2018 - 2030 (USD Million)

Chapter 6. End-Use Business Analysis

  • 6.1. DNA Polymerases Market: End-Use Movement Analysis
  • 6.2. Pharmaceutical & Biotechnology Companies
    • 6.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 6.3. Academic & Research Institutes
    • 6.3.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 6.4. Hospitals & Diagnostic Centers
    • 6.4.1. Hospitals & Diagnostic Centers Market, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Other End-uses Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. DNA Polymerases Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. SWOT Analysis
    • 7.2.2. North America DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.2.3. U.S.
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. U.S. DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.2.4. Canada
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Target Disease Prevalence
      • 7.2.4.3. Competitive Scenario
      • 7.2.4.4. Canada DNA Polymerases Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. SWOT Analysis
    • 7.3.2. Europe DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Germany DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.3.4. UK
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. UK DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. France DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Italy DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.3.7. Spain
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Spain DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.3.8. Denmark
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Denmark DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.3.9. Sweden
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Sweden DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.3.10. Norway
      • 7.3.10.1. Key Country Dynamics
      • 7.3.10.2. Target Disease Prevalence
      • 7.3.10.3. Competitive Scenario
      • 7.3.10.4. Norway DNA Polymerases Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. SWOT Analysis
    • 7.4.2. Asia Pacific DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Japan DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.4.4. China
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. China DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. India DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. South Korea DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.4.7. Australia
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Australia DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.4.8. Thailand
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Target Disease Prevalence
      • 7.4.8.3. Competitive Scenario
      • 7.4.8.4. Thailand DNA Polymerases Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. SWOT Analysis
    • 7.5.2. Latin America DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.5.3. Brazil
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Brazil DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Mexico DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.5.5. Argentina
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Argentina DNA Polymerases Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. SWOT Analysis
    • 7.6.2. MEA DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.6.3. South Africa
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. South Africa DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.6.4. Saudi Arabia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Saudi Arabia DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.6.5. UAE
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. UAE DNA Polymerases Market, 2018 - 2030 (USD Million)
    • 7.6.6. Kuwait
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Target Disease Prevalence
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Kuwait DNA Polymerases Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share Analysis, 2022
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific, Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Agilent Technologies
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Merck KGaA
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Danaher
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. QIAGEN
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Hoffmann-La Roche Ltd
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Bio-Rad Laboratories, Inc.;
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Takara Bio, Inc.
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Promega Corporation
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. New England Biolabs
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • TABLE 1 List of Abbreviations
  • TABLE 2 Global DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 3 Global DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 4 Global DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 5 Global DNA polymerases market, by region, 2018 - 2030 (USD Million)
  • TABLE 6 North America DNA polymerases market, by country, 2018 - 2030 (USD Million)
  • TABLE 7 North America DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 8 North America DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 9 North America DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 10 U.S. DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 11 U.S. DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 12 U.S. DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 13 Canada DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 14 Canada DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 15 Canada DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 16 Europe DNA polymerases market, by country, 2018 - 2030 (USD Million)
  • TABLE 17 Europe DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 18 Europe DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 19 Europe DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 20 Germany DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 21 Germany DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 22 Germany DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 23 UK DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 24 UK DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 25 UK DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 26 France DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 27 France DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 28 France DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 29 Italy DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 30 Italy DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 31 Italy DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 32 Spain DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 33 Spain DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 34 Spain DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 35 Denmark DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 36 Denmark DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 37 Denmark DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 38 Sweden DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 39 Sweden DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 40 Sweden DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 41 Norway DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 42 Norway DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 43 Norway DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 44 Asia Pacific DNA polymerases market, by country, 2018 - 2030 (USD Million)
  • TABLE 45 Asia Pacific DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 46 Asia Pacific DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 47 Asia Pacific DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 48 China DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 49 China DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 50 China DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 51 Japan DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 52 Japan DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 53 Japan DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 54 India DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 55 India DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 56 India DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 57 South Korea DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 58 South Korea DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 59 South Korea DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 60 Australia DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 61 Australia DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 62 Australia DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 63 Thailand DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 64 Thailand DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 65 Thailand DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 66 Latin America DNA polymerases market, by country, 2018 - 2030 (USD Million)
  • TABLE 67 Latin America DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 68 Latin America DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 69 Latin America DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 70 Brazil DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 71 Brazil DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 72 Brazil DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 73 Mexico DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 74 Mexico DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 75 Mexico DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 76 Argentina DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 77 Argentina DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 78 Argentina DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 79 Middle East & Africa DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 80 Middle East & Africa DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 81 Middle East & Africa DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 82 South Africa DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 83 South Africa DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 84 South Africa DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 85 Saudi Arabia DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 86 Saudi Arabia DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 87 Saudi Arabia DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 88 UAE DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 89 UAE DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 90 UAE DNA polymerases market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 91 Kuwait DNA polymerases market, by type, 2018 - 2030 (USD Million)
  • TABLE 92 Kuwait DNA polymerases market, by application, 2018 - 2030 (USD Million)
  • TABLE 93 Kuwait DNA polymerases market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain-based sizing & forecasting
  • FIG. 6 Market formulation & validation
  • FIG. 7 DNA polymerases market segmentation
  • FIG. 8 Market snapshot, 2022
  • FIG. 9 Market trends & outlook
  • FIG. 10 Market driver relevance analysis (current & future impact)
  • FIG. 11 Market restraint relevance analysis (current & future impact)
  • FIG. 12 SWOT analysis, by factor (political & legal, economic and technological)
  • FIG. 13 Porter's five forces analysis
  • FIG. 14 Market penetration & growth prospect mapping, 2022
  • FIG. 15 Global DNA polymerases market: type movement analysis
  • FIG. 16 Global DNA polymerases market, for Taq polymerase, 2018 - 2030 (USD Million)
  • FIG. 17 Global DNA polymerases market, for Pfu polymerase, 2018 - 2030 (USD Million)
  • FIG. 18 Global DNA polymerases market, for proprietary enzyme blends, 2018 - 2030 (USD Million)
  • FIG. 19 Global DNA polymerases market, for other types, 2018 - 2030 (USD Million)
  • FIG. 20 Global DNA polymerases market: application movement analysis
  • FIG. 21 Global DNA polymerases market, for polymerase chain reaction, 2018 - 2030 (USD Million)
  • FIG. 22 Global DNA polymerases market, for DNA sequencing, 2018 - 2030 (USD Million)
  • FIG. 23 Global DNA polymerases market, for DNA cloning, 2018-030, (USD Million)
  • FIG. 24 Global DNA polymerases market, for other applications, 2018 - 2030 (USD Million)
  • FIG. 25 Global DNA polymerases market: end-use movement analysis
  • FIG. 26 Global DNA polymerases market, for pharmaceutical and biotechnology companies , 2018 - 2030 (USD Million)
  • FIG. 27 Global DNA polymerases market, for academic and research institute, 2018 - 2030 (USD Million)
  • FIG. 28 Global DNA polymerases market, for hospital and diagnostic centers, 2018 - 2030 (USD Million)
  • FIG. 29 Global DNA polymerases market, for other end-uses, 2018 - 2030 (USD Million)
  • FIG. 30 Regional marketplace: key takeaways
  • FIG. 31 Regional outlook, 2022 & 2030
  • FIG. 32 Global DNA polymerases market: region movement analysis
  • FIG. 33 North America DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 34 U.S. DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 35 Canada DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 36 Europe DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 37 Germany DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 38 UK DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 39 France DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 40 Italy DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 41 Spain DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 42 Denmark DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 43 Sweden DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 44 Norway DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 45 Asia Pacific DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 46 Japan DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 47 China DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 48 India DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 49 Australia DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 50 South Korea DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 51 Thailand DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 52 Latin America DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 53 Brazil DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 54 Mexico DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 55 Argentina DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 56 Middle East and Africa DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 57 South Africa DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 58 Saudi Arabia DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 59 UAE DNA polymerases market, 2018 - 2030 (USD Million)
  • FIG. 60 Kuwait DNA polymerases market, 2018 - 2030 (USD Million)